These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 9621157

  • 1. Fixed drug eruption due to metronidazole and tinidazole without cross-sensitivity to secnidazole.
    Thami GP, Kanwar AJ.
    Dermatology; 1998; 196(3):368. PubMed ID: 9621157
    [No Abstract] [Full Text] [Related]

  • 2. Recurrent fixed drug eruption due to metronidazole elicited by patch test with tinidazole.
    Prieto A, De Barrio M, Infante S, Torres A, Rubio M, Olalde S.
    Contact Dermatitis; 2005 Sep; 53(3):169-70. PubMed ID: 16128758
    [No Abstract] [Full Text] [Related]

  • 3. Fixed drug eruption with ornidazole having cross-sensitivity to secnidazole but not to other nitro-imidazole compounds: a case report.
    Sanmukhani J, Shah V, Baxi S, Tripathi C.
    Br J Clin Pharmacol; 2010 Jun; 69(6):703-4. PubMed ID: 20565463
    [No Abstract] [Full Text] [Related]

  • 4. Fixed drug eruption with albendazole and it's cross-sensitivity with metronidazole--a case report.
    Mahboob A, Haroon TS.
    J Pak Med Assoc; 1998 Oct; 48(10):316-7. PubMed ID: 10087757
    [No Abstract] [Full Text] [Related]

  • 5. Fixed drug eruption and cross-reactivity between tinidazole and metronidazole.
    Mishra D, Mobashir M, Zaheer MS.
    Int J Dermatol; 1990 Dec; 29(10):740. PubMed ID: 2148563
    [No Abstract] [Full Text] [Related]

  • 6. Fixed drug eruption due to tinidazole with cross-reactivity with metronidazole.
    Kanwar AJ, Sharma R, Rajagopalan M, Kaur S.
    Dermatologica; 1990 Dec; 180(4):277. PubMed ID: 2141581
    [No Abstract] [Full Text] [Related]

  • 7. [A therapeutic trial in Giardia muris infection in the mouse with metronidazole, tinidazole, secnidazole and furazolidone].
    Cruz CC, Ferrari L, Sogayar R.
    Rev Soc Bras Med Trop; 1997 Dec; 30(3):223-8. PubMed ID: 9273569
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials.
    Pasupuleti V, Escobedo AA, Deshpande A, Thota P, Roman Y, Hernandez AV.
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2733. PubMed ID: 24625554
    [Abstract] [Full Text] [Related]

  • 9. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
    Cañete R, Noda AL, Rodríguez M, Brito K, Herrera E, Kofoed PE, Ursing J.
    Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tinidazole (Tindamax) - a new anti-protozoal drug.
    Med Lett Drugs Ther; 2004 Aug 30; 46(1190):70-2. PubMed ID: 15375353
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fixed drug eruption due to cross reaction between two azoles used for different indications.
    Bansal A, Kumari R, Ramam M.
    Indian J Dermatol Venereol Leprol; 2008 Aug 30; 74(1):81. PubMed ID: 18193506
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.